Pregled bibliografske jedinice broj: 644578
Catalytic hydrolysis of tabun and soman utilizing cholinesterases and oximes
Catalytic hydrolysis of tabun and soman utilizing cholinesterases and oximes // Abstracts of International Conference Biocatalysis-2013: Fundamentals & Applications, Moskva, Rusija
Moskva, Ruska Federacija: Innovations and High TechnologiesMSU Ltd., 2013. (pozvano predavanje, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 644578 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Catalytic hydrolysis of tabun and soman utilizing cholinesterases and oximes
Autori
Kovarik , Zrinka ; Maček , Nikolina ; Katalinić , Maja ; Radić , Zoran ; Taylor, Palmer
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Abstracts of International Conference Biocatalysis-2013: Fundamentals & Applications, Moskva, Rusija
/ - : Innovations and High TechnologiesMSU Ltd., 2013
Skup
International Conference Biocatalysis-2013: fundamentals & applications
Mjesto i datum
Moskva, Ruska Federacija, 02.07.2013. - 05.07.2013
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
tabun; soman; acetylcholinestrase; human AChE mutant; bioscavening
Sažetak
A high toxicity of nerve agents, tabun and soman, arises from the irreversible inhibition of acetylcholinesterase (AChE ; EC 3.1.1.7), important enzyme in cholinergic neurotransmission. The inhibition of AChE in central and peripheral tissue results in accumulation of neurotransmitter acetylcholine at vital cholinergic sites, which in turn leads to life-threatening toxic manifestations. Such poisonings call for immediate treatment, which usually consists of a combined administration of anticholinergic drugs and an oxime as the reactivator of AChE. However, this approach still has its limitations mostly due to the inability of currently applied reactivators to reactivate tissue AChE efficiently particularly when it is repeatedly phosphorylated by the excess of tabun or soman remaining in circulation upon exposure. Our recent studies have shown that AChE mutagenesis enables oximes to substantially accelerate the reactivation of the soman-enzyme conjugate that resists aging. We created human AChE mutant, Y337A/F338A, to combine the increased accessibility of conjugated phosphorus to oximes provided by the Y337A mutation with the aging resistance of the F338A mutation. On the other hand, we designed a library of new oximes where we identified efficient reactivators of the Y337A human AChE inhibited by tabun that accelerate reactivation rate for 10-times in comparison to the AChE w.t. Our overall findings indicate that distinct human AChE mutants have catalytic bioscavenging potential when combined with oximes, proven effective in soman or tabun in vitro exposure. (Supported by NIH UO1NS058046 and R21NS072086 and by IMROH 022-0222148-2889)
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Projekti:
022-0222148-2889 - Interakcije organofosfata, karbamata i određenih liganada s esterazama (Kovarik, Zrinka, MZOS ) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb